After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Unilever withdraws Dove and Tresemmé shampoos, carries cancer risk; use with caution
World's leading FMCG company Unilever has withdrawn many of its dry shampoos including Dove and T
Shimla Masjid Case: The dispute over Sanjauli Masjid in Shimla, the capital of Himachal Pradesh,
COVID-19: Sharp decline in corona cases, infection rate 3.50 percent, but cases increased in Delhi
The corona infection in the country is fluctuating daily. In the last 24 hours, 12,751 new cases
On the 135th day of the Russia-Ukraine war, Ukrainian President Volodymyr Zelensky decided to rem
NIA has come to know of a new hi-tech network of terror in the country. NIA sources said that the
After the huge loss of life and property due to the landslide in Wayanad, Kerala, amid relief and
Jio Bharat V2: Jio launched a 4G phone for Rs 999, only Rs 123 plan came with it
Reliance Jio has launched the 4G phone 'Jio Bharat V2'. 'Jio Bharat V2' will be available at very
Due to poor fielding in the last over, Team India lost the first ODI against Bangladesh by one wi
Monsoon is raining from the hilly areas of Jammu and Kashmir to Mayanagari Mumbai. According to t
Gujarat Titans vice-captain and spin magician Rashid Khan has said that he is constantly working
